In seeking to evaluate the role of exogenous HB-EGF in the context of NEC, Dvorak and colleagues demonstrated that either the oral administration of HB-EGF or EGF significantly reduced NEC in a premature rat model through increased production of MUC2, a secretory mucin [33]. This evidence concerns the gene MUC2 and necrotizing enterocolitis.